Patents Assigned to OPENCELL TECHNOLOGIES, INC.
  • Intracellular delivery and transfection methods and devices
    Patent number: 9725709
    Abstract: Embodiments of the present disclosure provide a multistage procedure for treatment of biological samples (e.g., living cells with membranes, and the like) with a substance (e.g., a drug, DNA, RNA, plasmids, and other biomolecules or materials) to achieve more efficacious intracellular delivery and transfection.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: August 8, 2017
    Assignee: OPENCELL TECHNOLOGIES, INC.
    Inventors: John Mark Meacham, Kiranmai Durvasula, Andrei G. Fedorov, Fahrettin Levent Degertekin, Akash Mehta